UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. __ )
La Jolla Pharmaceutical Company
--------------------------------------------------------------------------------
(Name of issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of class of securities)
503459109
--------------------------------------------------------------------------------
(CUSIP number)
August 28, 2000
--------------------------------------------------------------------------------
(Date of Event which requires filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
schedule is filed:
/ / Rule 13d-1 (b)
/X/ Rule 13d-1 (c)
/ / Rule 13d-1 (d)
<PAGE>
---------------------------------
CUSIP No. 503459109
---------------------------------
-------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Deutsche Bank AG
-------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) / /
-------- -----------------------------------------------------------------------
3 SEC USE ONLY
-------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Federal Republic of Germany
---------------------------- ------ --------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
0
------ --------------------------------------------
BENEFICIALLY OWNED BY SHARED VOTING POWER
6 3,044,783*
------ --------------------------------------------
EACH REPORTING SOLE DISPOSITIVE POWER
7 0
------ --------------------------------------------
PERSON WITH SHARED DISPOSITIVE POWER
8 3,044,783*
-------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,044,783*
-------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES / /
-------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.4%**
-------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
HC, BK, CO
-------- -----------------------------------------------------------------------
* Included in this figure are the securities reported by Deutsche Funds Holding
GmbH and DWS Investment S.A., Luxembourg on the following cover pages.
** Included in this percentage is the percentage of securities reported by
Deutsche Funds Holding GmbH and DWS Investment S.A., Luxembourg on the following
cover pages.
<PAGE>
---------------------------------
CUSIP No. 503459109
---------------------------------
-------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Deutsche Funds Holding GmbH
-------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) / /
-------- -----------------------------------------------------------------------
3 SEC USE ONLY
-------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Federal Republic of Germany
------------------------------ ------ ------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
0
------ ------------------------------------------
BENEFICIALLY OWNED BY SHARED VOTING POWER
6 2,260,300*
------ ------------------------------------------
EACH REPORTING SOLE DISPOSITIVE POWER
7 0
------ ------------------------------------------
PERSON WITH SHARED DISPOSITIVE POWER
8 2,260,300*
-------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,260,300*
-------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES / /
-------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.2%**
-------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
HC
-------- -----------------------------------------------------------------------
*Included in this figure are the securities reported by DWS Investment S.A.,
Luxembourg on the following cover page.
**Included in this percentage is the percentage of securities reported by DWS
Investment S.A., Luxembourg.
<PAGE>
---------------------------------
CUSIP No. 503459109
---------------------------------
-------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
DWS Investment S.A., Luxembourg
-------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) / /
-------- -----------------------------------------------------------------------
3 SEC USE ONLY
-------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
[Federal Republic of Germany]
------------------------------ ------ ------------------------------------------
NUMBER OF SHARES 5 SOLE VOTING POWER
0
------ ------------------------------------------
BENEFICIALLY OWNED BY SHARED VOTING POWER
6 2,260,300
------ ------------------------------------------
EACH REPORTING SOLE DISPOSITIVE POWER
7 0
------ ------------------------------------------
PERSON WITH SHARED DISPOSITIVE POWER
8 2,260,300
-------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,260,300
-------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES / /
-------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.2%
-------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
-------- -----------------------------------------------------------------------
<PAGE>
Item 1(a). Name of Issuer:
La Jolla Pharmaceutical Company (the "Issuer")
Item 1(b). Address of Issuer's Principal Executive Offices:
The address of the Issuer's principal executive offices is
6455 Nancy Ridge Drive, San Diego, CA 92121.
Item 2(a). Name of Person Filing:
This statement is filed on behalf of Deutsche Bank AG
("DBAG"), Deutsche Funds Holding GmbH ("DWSG"), and DWS Investment S.A.,
Luxembourg (DWSI", and together with DBAG and DWSG, the "Reporting Persons").
Item 2(b). Address of Principal Business Office or, if none, Residence:
The principal place of business of DBAG is Taunusanlage 12,
D-60325, Frankfurt am Main, Federal Republic of Germany.
The principal place of business of DWSG is Feldbergstrasse 22,
60323, Frankfurt, Federal Republic of Germany.
The principal place of business of DWSI is 2, Boulevard Konrad
Adenauer, 1115 Luxembourg.
Item 2(c). Citizenship:
The citizenship of each of the Reporting Persons is set forth
on the applicable cover page.
Item 2(d). Title of Class of Securities:
The title of the securities is Common Stock (the "Common
Stock").
Item 2(e). CUSIP Number:
The CUSIP number of the Common Stock is set forth on each
cover page.
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b) or (c), check whether the person filing is a:
(a) / / Broker or dealer registered under section 15 of the
Act;
(b) / / Bank as defined in section 3(a)(6) of the Act;
(c) / / Insurance Company as defined in section 3(a)(19) of
the Act;
(d) / / Investment Company registered under section 8 of the
Investment Company Act of 1940;
(e) / / An investment adviser in accordance with Rule 13d-1
(b)(1)(ii)(E);
(f) / / An employee benefit plan, or endowment fund in
accordance with Rule 13d-1 (b)(1)(ii)(F);
(g) / / A parent holding company or control person in
accordance with Rule 13d-1 (b)(1)(ii)(G);
(h) / / A savings association as defined in section 3(b) of
the Federal Deposit Insurance Act;
(i) / / A church plan that is excluded from the definition
of an investment company under section 3(c)(14) of
the Investment Company Act of 1940;
(j) / / Group, in accordance with Rule 13d-1 (b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1 (c), check
this box. /X/
Item 4. Ownership.
(a) Amount beneficially owned:
Each of the Reporting Persons owns the amount of the
Common Stock as set forth on the applicable cover page.
(b) Percent of class:
Each of the Reporting Persons owns the percentage of
the Common Stock as set forth on the applicable cover page.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Each of the Reporting Persons has the sole
power to vote or direct the vote of the Common Stock
as set forth on the applicable cover page.
(ii) shared power to vote or to direct the vote:
Each of the Reporting Persons has the shared
power to vote or direct the vote of the Common Stock
as set forth on the applicable cover page.
(iii) sole power to dispose or to direct the
disposition of:
Each of the Reporting Persons has the sole
power to dispose or direct the disposition of the
Common Stock as set forth on the applicable cover
page.
(iv) shared power to dispose or to direct the
disposition of:
Each of the Reporting Persons has the shared
power to dispose or direct the disposition of the
Common Stock as set forth on the applicable cover
page.
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
[Item 6]. Ownership of More than Five Percent on Behalf of Another
Person.
[Mutual fund clients of the Reporting Persons have the
ultimate right to any dividends from the Common Stock and the proceeds from the
sale of the Common Stock.]
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company.
The following are subsidiaries of DBAG and/or DWSG which hold
Common Stock included in the figures on the cover pages: DWS Investment GmbH,
Deutsche Vermogensbildungsgesellschaft mbH, Deutsche Asset Management
Investmentgesellschaft GmbH and Deutsche Asset Management International GmbH.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: September 11, 2000
DEUTSCHE BANK AG
By: /s/ Dieter Eisele
--------------------------------
Name: Dr. Dieter Eisele
Title: Group Head of Compliance
By: /s/ Christoph Kirschhofer
--------------------------------
Name: Christoph Kirschhofer
Title: Director
<PAGE>
EXHIBIT 1
Consent of Deutsche Funds Holding GmbH
The undersigned agrees that the Schedule 13G executed by
Deutsche Bank AG to which this statement is attached as an exhibit is filed on
behalf of Deutsche Bank AG, Deutsche Funds Holding GmbH and DWS Investment S.A.,
Luxembourg pursuant to Rule 13d-1(k)(1) of the Securities Exchange Act of 1934.
Dated: September 11, 2000
DEUTSCHE FUNDS HOLDING GMBH
By: /s/ Peter Grafunder
--------------------------------
Name: Peter Grafunder
Title: Managing Director
By: /s/ Ralf Ring
--------------------------------
Name: Ralf Ring
Title: Compliance Officer
<PAGE>
EXHIBIT 2
Consent of DWS Investment S.A., Luxembourg
The undersigned agrees that the Schedule 13G executed by
Deutsche Bank AG to which this statement is attached as an exhibit is filed on
behalf of Deutsche Bank AG, Deutsche Funds Holding GmbH and DWS Investment S.A.,
Luxembourg pursuant to Rule 13d-1(k)(1) of the Securities Exchange Act of 1934.
Dated: September 11, 2000
DWS INVESTMENT S.A., LUXEMBOURG
By: /s/ Peter Grafunder
--------------------------------
Name: Peter Grafunder
Title: Managing Director
By: /s/ Ralf Ring
--------------------------------
Name: Ralf Ring
Title: Compliance Officer
